Page 8 - CIRN Annual Report 2017

meningococcal B disease in the Saguenay Lac St Jean regions of
Quebec and Wolfville, Nova Scotia. In addition to the successful
surveillance for a new meningococcal B vaccine used during

a mass immunization campaign following an outbreak of
In 2014 and 2015, CANVAS rapidly implemented safety

Canadian National Vaccine
influenza vaccine safety surveillance campaign, CANVAS will also continue to monitor vaccine safety for other and new vaccines, and provide a platform for vaccine acceptability studies.
Safety Network (CANVAS)

The Canadian Vaccine Safety Network (CANVAS) assesses
Calgary, Toronto, Ottawa, Quebec City, Sherbrooke, and Halifax.
weekly safety reports to the Public Health Agency of Canada in
providing safety data in this year’s cohort. CANVAS submitted
October, November and December. Safety information on the
following 7 influenza vaccines was captured: Flumist, Fluviral,
campaigns. The network is comprised of sites in Vancouver,
vaccine safety immediately after implementation of vaccine
surveillance campaign, with more than 35,000 participants
CANVAS initiated its eight annual influenza vaccine safety

Vaxigrip, Agriflu, Fluzone, Influvac and Fluad. No unexpected side
reported among 2016 vaccinees.

effects were observed in adults or children following the 2016 seasonal vaccines, although a slighter higher rate of events was

6